Understand the source comparison
Best Peptides for Alcohol Damage Repair: Mechanism Comparison
Thymalin Thymus / Immune System Restores thymic peptide output; normalizes T-cell differentiation and reduces systemic inflammation Preclinical + observational human studies Subcutaneous injection Requires sustained use (14–21 days minimum) for measurable immu
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Thymalin
- Thymus / Immune System
- Restores thymic peptide output; normalizes T-cell differentiation and reduces systemic inflammation
- Preclinical + observational human studies
- Subcutaneous injection
- Requires sustained use (14–21 days minimum) for measurable immune reconstitution
- BPC-157
- Gastric mucosa / Liver
- Upregulates VEGF and FGF to accelerate angiogenesis and tissue remodeling; stabilizes gut barrier
- Animal models only
- Subcutaneous or oral (gastric protection)
- Short half-life (~4 hours); no Phase 3 human trials for alcoholic liver disease
- Cerebrolysin
- Brain (hippocampus, prefrontal cortex)
- Delivers neurotrophic factors (BDNF, NGF, CNTF) that support synaptic repair and neurogenesis
- Phase 3 clinical trials in cognitive impairment
- Intravenous infusion
- Requires clinical administration; high cost; porcine-derived (allergen concern)
- Dihexa
- Brain (hippocampus)
- Binds HGF receptors to promote dendritic spine growth and enhance long-term potentiation
- Preclinical models only
- Oral or subcutaneous
- Investigational status; no human safety data in chronic dosing
- Bottom Line
- The peptide choice depends entirely on the primary damage type: immune dysfunction (Thymalin), gastric/hepatic injury (BPC-157), or cognitive deficits (Cerebrolysin/Dihexa). No peptide addresses all alcohol-related pathologies. Effective protocols combine targeted peptides with standard medical management (thiamine, folate, abstinence support).